254 related articles for article (PubMed ID: 8813597)
21. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
Taniguchi H; Nagasaki M; Tamaki H
Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
[TBL] [Abstract][Full Text] [Related]
22. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
[TBL] [Abstract][Full Text] [Related]
23. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
24. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
Letari O; Mennuni L; Revel L; Colombo S; Makovec F
Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K
Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805
[TBL] [Abstract][Full Text] [Related]
28. 2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist.
Hull RA; Shankley NP; Harper EA; Gerkowitch VP; Black JW
Br J Pharmacol; 1993 Mar; 108(3):734-40. PubMed ID: 7682135
[TBL] [Abstract][Full Text] [Related]
29. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
D'Amato M; Stamford IF; Bennett A
Br J Pharmacol; 1991 Feb; 102(2):391-5. PubMed ID: 2015421
[TBL] [Abstract][Full Text] [Related]
30. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K
Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501
[TBL] [Abstract][Full Text] [Related]
31. Characterization of neuronal cholecystokinin receptor by L-364,718 in Auerbach's plexus.
Zelles T; Harsing LG; Vizi ES
Eur J Pharmacol; 1990 Mar; 178(1):101-4. PubMed ID: 2332026
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological study of gastrin-mediated amylase release in pancreatic acinar cells (AR4-2J).
Bertrand V; Bastié MJ; Bigaud C; Pyronnet S; Vaysse N; Pradayrol L
Regul Pept; 1994 Dec; 54(2-3):513-25. PubMed ID: 7536336
[TBL] [Abstract][Full Text] [Related]
33. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
Schutte IW; Akkermans LM; Kroese AB
J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
35. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
Tsubo K; Arai M; Omachi H; Mitamura K
J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
[TBL] [Abstract][Full Text] [Related]
36. A cholecystokinin receptor antagonist, loxiglumide, stimulates biliary secretion in conscious rats.
Watanabe N; Otsuki M
Eur J Pharmacol; 1994 Nov; 264(3):331-6. PubMed ID: 7698173
[TBL] [Abstract][Full Text] [Related]
37. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
[TBL] [Abstract][Full Text] [Related]
38. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
39. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Corp ES; McQuade J; Moran TH; Smith GP
Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
